查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847899

兽医整形外科植入市场：按动物类型、植入类型、材料类型、最终用户和应用 - 全球预测 2025-2032

Veterinary Orthopedic Implants Market by Animal Type, Implant Type, Material Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，兽医整形外科植入市场将成长至 10.6165 亿美元，复合年增长率为 9.60%。

主要市场统计数据
基准年2024年 5.0985亿美元
预计2025年 5.5988亿美元
预测年份：2032年 10.6165亿美元
复合年增长率（%） 9.60%

关于影响现代兽医整形外科植入实践的临床需求、技术创新和供应链动态的全面情况概述

本导言将临床需求、技术进步和商业性动态整合在一起，组装当代兽医整形外科植入的格局。小型伴侣动物、大型牲畜以及特定外来物种的临床应用日益成熟，推动了对兼具机械可靠性和生物相容性的植入的差异化需求。诊断影像、外科技术和术后护理的进步正在扩大植入修復的适用病例范围，同时，材料和製造流程的同步改进也正在推动新的产品配置和微创给药方法的开发。

除了临床催化剂之外，生态系层面的变化也在重塑采购和部署。兽医诊所和门诊手术中心越来越重视库存合理化和供应商整合，而学术中心和研究机构则正在推动客製化和实验性植入的发展。这些因素，加上更广泛的供应链考量，包括原材料植入、法规遵循和分销管道优化，正在创造一个竞争格局，临床差异化和营运效率将决定市场领导地位。

从传统的实践模式转向更专业、更技术驱动的模式转变，需要在临床医生培训、设备检验和最终用户教育方面进行协同投资。因此，那些将产品设计与临床医生工作流程相结合、强调循证性能并展示可预测物流的相关人员，将获得更广泛的采用和永续的价值获取。

生医材料、积层製造和综合服务模式的融合进步如何重塑临床期望和竞争优势

生物材料、製造和数位工具的创新融合正在重新定义产品价值提案，并改变产业格局。积层製造和先进影像处理带来的患者专属解决方案正在改变人们对贴合度、功能和手术效率的期望，推动外科医生接受能够缩短术中时间并改善解剖完整性的植入。同时，日趋成熟的生物可吸收聚合物和陶瓷涂层技术正在拓展临时固定和表面增强骨整合的选择，迫使临床医生权衡长期生物学结果与即时机械稳定性。

在营运方面，销售和服务模式正在从纯粹的交易关係转变为整合培训、仪器和数位支援的一体化服务。兽医、生物医学工程师和产品开发人员之间日益加强的跨学科合作进一步强化了这一转变，从而实现了迭代改进，将临床反馈转化为快速的设计週期。此外，对永续性和生命週期影响的日益关注也影响着材料和製造流程的选择，一些製造商开始采用可回收包装、精益生产和本地化供应链，以缩短前置作业时间并降低碳排放强度。

总的来说，这些变化正在创造一个市场，在这个市场中，产品开发的灵活性、经过验证的临床结果和强大的售后支援将决定竞争优势并加速临床应用。

定性评估2025年后关税调整将如何重塑整个植入价值链的筹资策略、材料选择和供应链弹性

2025年左右实施的关税政策变化的累积影响，波及到兽医整形外科植入製造商和最终用户的采购、定价策略和供应链配置。进口医用级金属和成品植入的关税上调，增加了对筹资策略的审查力度，导致许多组织重新评估其供应商组合，并考虑替代材料路线或区域製造合作伙伴关係。因此，采购团队越来越多地评估总到岸成本，并将情境规划纳入其年度采购週期，以在保护利润率的同时，保持临床供应的连续性。

同时，一些製造商正在多角化发展近岸外包和製造外包製造，以降低进口关税和运输波动的风险。虽然这些调整通常需要前期投资和重新检验製造流程，但也创造了缩短前置作业时间和提高对临床医生需求应对力的机会。同时，经销商和医院系统正在重新协商合约条款，寻求延长库存协议，并与製造商更紧密地合作，以预先部署关键的植入线。

临床医生正在权衡钛等高端材料的优势与不銹钢和新兴生物可吸收材料等更具成本效益的替代品，并兼顾病例的复杂性和长期疗效。总而言之，关税环境加速了整个价值链的策略调整，将供应链弹性、材料灵活性和本地製造提升为持久的优先事项。

详细的細項分析揭示了动物类型、植入设计、材料科学、最终用户采购和临床应用如何影响产品策略

节段级动态揭示了临床需求、材料科学和最终用户行为的交集，从而创造了差异化的机会。透过动物物种的分析，可以发现小动物（如猫和狗）、大型动物（如牛、马和猪）和外来动物（如鸟类和爬虫类）有不同的需求模式。每个节段都有独特的生物力学和解剖学限制，这些限制会影响植入的几何形状、固定策略和术后方案。同样，植入类型也很重要。钢板和螺丝有多种类型，例如动态加压钢板和锁定钢板，可治疗各种骨折类型，而髓内钉有动态和实心两种形式，可提供负载共用解决方案，通常是长骨稳定的首选。交锁钉也为特定适应症提供旋转稳定性。

生物可吸收聚合物提供临时支撑并减少植入移除的需要，陶瓷涂层增强组织-植入界面的骨整合，不銹钢和钛等金属提供长期结构可靠性。最终用户细分揭示了门诊手术中心、研究和学术机构、兽医诊所和全方位服务兽医医院之间不同的采购行为。门诊手术中心优先考虑成本效益和存货周转，学术机构优先考虑创新和证据生成，诊所强调工作流程简化，医院在复杂性和全面手术组合的需求之间取得平衡。最后，按应用细分——骨折固定、关节重组、韧带修復和截骨术——将临床结果与设计要求相匹配，并确定研发投资的优先顺序。整合这些层面可以製定有针对性的产品策略，使设计特点与每个临床和操作环境的细微需求保持一致。

区域比较见解，重点介绍美洲、欧洲和亚太市场的监管复杂性、临床采用模式和分销细微差别

区域动态影响着法规环境、临床医生培训生态系统和分销网络，从而在美洲、欧洲、中东和非洲以及亚太地区形成了不同的策略考量。在美洲，强大的私人诊所渗透率、成熟的伴侣动物护理市场以及先进的外科培训支持新植入技术的快速应用。监管途径倾向于在安全性和临床可及性之间取得平衡，为拥有可靠临床证据的创新者创造了可预测的管道。

欧洲、中东和非洲的报销结构和管理体制各不相同，因此需要采取适应性强的市场进入策略。西欧中心通常在早期临床应用和合作研究方面处于领先地位，而中东和非洲市场在基础设施和采购成熟度方面差异巨大，影响了高端植入应用的可行性。亚太地区拥有众多大型公立医院、不断发展的私人专科诊所以及快速扩张的兽医诊所，这既带来了规模效应，也增加了营运的复杂性。本地製造能力（尤其是在亚太地区的主要枢纽）可以降低成本并提高应对力，但也带来了专注于成本/价值权衡的国内生产商的竞争压力。

总的来说，区域见解表明，成功的市场进入和扩张需要量身定制的监管策略、本地化的临床医生参与计划以及反映不同付款人、提供者和物流现实的灵活分销模式。

该公司的策略能力透过综合服务模式、重点产品组合、灵活製造和临床参与推动商业性成功。

企业级动态的核心在于超越产品属性，涵盖製造灵活性、临床伙伴关係以及支援应用的服务生态系统。领先的公司正在投资模组化设备、外科医生培训学院和数位规划平台，以降低执行风险并为采购决策者创造转换成本。一些製造商强调垂直整合的供应链，以确保关键原材料供应并加速产品迭代；而另一些製造商则寻求战略伙伴关係和製造外包，以便在无需大量资本支出的情况下快速扩张。

产品组合策略也各不相同，有些公司优先考虑产品的广度，提供涵盖多种物种和应用的综合植入系统，并与医院网路建立批量采购关係。另一些公司则专注于利基解决方案，例如生物可吸收植入和针对特定物种的设计，以获取优质的临床市场份额。整体而言，成功的公司会进行严格的上市后植入，以同侪审查的形式发布临床结果，并积极与意见领袖合作，以检验设备在现实环境中的表现。最后，商业性卓越性越来越多地由整合服务产品来定义，例如器械再利用计划、灭菌物流和远端手术计划支持，这些产品可以减少最终用户的操作摩擦并加强长期伙伴关係。

为产业领导者提供优先、可行的建议，以优化产品蓝图、加强供应链并透过数据和服务加速临床应用

行业领导者应采取一系列务实、优先的行动，以增强竞争地位并应对不断变化的市场压力。首先，加速临床应用，方法是将产品开发蓝图与临床医生的痛点相结合，并投资模组化系统和以外科医生为中心的设备，以减少手术时间和差异。其次，实现采购和製造业务的多元化，以减少关税波动带来的风险并缩短前置作业时间。

第三，我们将透过支持临床试验和註册研究来投资证据生成，这些试验和註册研究能够展示不同材料和植入类型的比较结果。第四，我们将扩展配套服务产品，将设备与培训、数位化规划和售后支援结合，以创建差异化的价值提案并提高客户维繫。第五，我们将根据区域差异来客製化打入市场策略，使我们的监管提交、定价方法和分销模式与区域付款人和供应商结构保持一致。最后，我们将与学术中心和专科转诊医院建立选择性合作伙伴关係，共同开发创新解决方案，并利用这些关係来加速临床医生教育和产品检验。这些行动将同时执行，以平衡短期商业性压力与长期差异化和成长潜力。

结合临床医生访谈、文献三角测量和供应链分析的透明、多方法研究途径检验了细分和场景洞察

本研究采用结构化、多方法研究方法，整合了原始研究和二手资料，以确保研究结果对决策者俱有相关性和可靠性。原始研究包括对执业兽医、采购专业人员和生物医学工程师的深入访谈，并辅以结构化的临床医生调查，以了解操作偏好和材料权衡。这些输入与二手资料（包括同行评审的临床文献、设备註册、监管备案以及公开的生产和分销数据）进行交叉引用，以检验趋势并识别新兴模式。

在方法论上，我们将动物种类、植入设计、材料属性、最终用户行为和应用与可观察的需求讯号进行映射，从而建立一个能够反映现实世界临床和商业决策的细分框架。我们的供应链调查方法着重于原料流、製造外包关係和通路结构，以评估营运风险和上市时间限制。所有分析均透过跨职能专家评审小组进行内部检验，以检验假设并确保解读的准确性。在适当的情况下，我们运用情境分析来探讨关税衝击、原料中断和新技术加速采用的影响，从而为韧性策略和机会之窗提供切实可行的见解。

研究结果凸显了创新、证据产生和运作弹性如何决定兽医整形外科植入物的领导地位

总而言之，兽医整形外科植入领域正处于曲折点，临床创新、材料科学和营运需求交织在一起，共同打造差异化的策略路径。那些优先考虑以临床医生为中心的设计、投资于循证医学并构建灵活製造和分销能力的相关人员，将最有可能获得持续的价值。关税压力凸显了供应链多元化和区域製造选择的重要性，而生物可吸收性、表面技术和积层製造技术的进步正在拓展可行的临床干预措施。

随着市场的发展，成功的定义将不再仅取决于设备性能，而在于能否提供能够减少临床摩擦、展现显着疗效优势并适应当地市场实际情况的整合解决方案。将严谨的商业性执行与在培训、临床伙伴关係和售后服务方面的有针对性的投资相结合的组织，将能够加速技术应用，改善患者疗效，并与关键终端用户建立长期合作关係。展望未来，循证、有韧性且以服务为导向的方法将使市场领导者与落后者脱颖而出。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 客製化 3D 列印整形外科植入在小动物患者中的应用日益增多
  • 提高生物可吸收材料在兽医骨固定装置中的整合度
  • 使用关节镜植入植入物的微创技术的需求快速成长
  • 越来越多地使用配备感测器的智慧植入来监测动物术后情况
  • 干细胞植入支架在增强宠物整形外科修復的进展
  • 扩展远端医疗平台以支援术后整形外科植入护理

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章动物整形外科植入市场（依动物类型）

  • 珍稀动物
    • 鸟
    • 爬虫类
  • 大型动物
    • 牛
    • 马
    • 猪
  • 小动物
    • 猫
    • 狗

第九章：动物整形外科植入市场（依植入类型）

  • 外固定装置
    • 环形固定装置
    • 单侧固定装置
  • 交锁钉
  • 髓内钉
    • 空心钉
    • 实心钉子
  • 钢板和螺丝
    • DCP版
    • 锁定钢板

第十章动物整形外科植入市场（依材料类型）

  • 生物可吸收聚合物
  • 陶瓷涂层
  • 不銹钢
  • 钛

第 11 章。动物整形外科植入市场（按最终用户）

  • 门诊手术中心
  • 研究和学术机构
  • 兽医诊所
  • 兽医诊所

第十二章动物整形外科植入市场（按应用）

  • 骨折固定
  • 关节重组
  • 韧带修復
  • 截骨术

第十三章动物整形外科植入市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章动物整形外科植入市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按国家/地区分類的动物整形外科植入物市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • DePuy Synthes, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • Smith & Nephew plc
    • Arthrex, Inc.
    • BioMedtrix, Inc.
    • IMEX Veterinary Inc.
    • Kyon AG
    • Orthomed, Inc.
    • B. Braun Melsungen AG
Product Code: MRR-FB6C9E792C19

The Veterinary Orthopedic Implants Market is projected to grow by USD 1,061.65 million at a CAGR of 9.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 509.85 million
Estimated Year [2025] USD 559.88 million
Forecast Year [2032] USD 1,061.65 million
CAGR (%) 9.60%

Comprehensive contextual overview connecting clinical demand, technological innovation, and supply chain dynamics shaping contemporary veterinary orthopedic implant practices

This introduction frames the contemporary context for veterinary orthopedic implants by connecting clinical need, technological progress, and commercial dynamics into an integrated narrative. Growing clinical sophistication across small companion animals, large livestock, and selected exotic species is driving differentiated demand for implants that combine mechanical reliability with biologic compatibility. Advances in imaging, surgical technique, and postoperative care have expanded the range of cases amenable to implant-based repair, while parallel improvements in materials and manufacturing have unlocked new product configurations and minimally invasive delivery methods.

In addition to clinical catalysts, ecosystem-level changes are reshaping procurement and deployment. Veterinary hospitals and ambulatory surgical facilities increasingly prioritize inventory rationalization and single-vendor contracting, even as academic centers and research institutes push the frontier of custom and experimental implants. These forces converge with broader supply chain considerations-raw material sourcing, regulatory compliance, and distribution channel optimization-to create a competitive landscape where clinical differentiation and operational efficiency define market leaders.

Transitioning from conventional practice patterns to a more specialized, technology-enabled model requires coordinated investment in clinician training, device validation, and end-user education. Consequently, stakeholders that align product design with clinician workflows, emphasize evidence-based performance, and demonstrate predictable logistics will achieve greater adoption and sustainable value capture.

How convergent advances in biomaterials, additive manufacturing, and integrated service models are reshaping clinical expectations and competitive advantage

The landscape is undergoing transformative shifts driven by convergent innovations in biomaterials, manufacturing, and digital tools that together redefine product value propositions. Patient-specific solutions enabled by additive manufacturing and advanced imaging are shifting expectations for fit, function, and surgical efficiency; surgeons are increasingly receptive to implants that reduce intraoperative time and improve anatomical congruence. Concurrently, the maturation of bioabsorbable polymers and ceramic-coating technologies is expanding options for temporary fixation and surface-enhanced osseointegration, prompting clinicians to weigh long-term biological outcomes alongside immediate mechanical stability.

Operationally, distribution and service models are migrating from purely transactional relationships to integrated service offerings that bundle training, instrumentation, and digital support. This shift is reinforced by a rise in cross-disciplinary collaboration between veterinary surgeons, biomedical engineers, and product developers, producing iterative refinements that translate clinical feedback into rapid design cycles. Furthermore, heightened attention to sustainability and lifecycle impacts influences material selection and manufacturing choices, nudging some manufacturers toward recyclable packaging, lean production, and regionalized supply chains to reduce lead times and carbon intensity.

Taken together, these transformative shifts are creating a market where agility in product development, demonstrated clinical outcomes, and robust post-sale support determine competitive advantage and accelerate adoption across practice settings.

Qualitative assessment of how tariff adjustments since 2025 have reshaped sourcing strategies, material choices, and supply chain resilience across the implant value chain

The cumulative impact of tariff policy changes implemented in and around 2025 has reverberated through procurement, pricing strategies, and supply chain configurations for manufacturers and end users of veterinary orthopedic implants. Tariff increases on imported medical-grade metals and finished implants have intensified scrutiny of sourcing strategies, prompting many organizations to reassess supplier portfolios and consider alternative material pathways or regional production partnerships. As a result, procurement teams have elevated total landed cost assessments and incorporated scenario planning into annual sourcing cycles to preserve margin while maintaining clinical supply continuity.

Meanwhile, some manufacturers have accelerated nearshoring and contract manufacturing diversification to mitigate exposure to import levies and shipping volatility. These adjustments often require upfront capital and revalidation of manufacturing processes, but they also create opportunities to shorten lead times and improve responsiveness to clinician demand. In parallel, distributors and hospital systems have renegotiated contractual terms, sought extended inventory agreements, and increased collaboration with manufacturers to preposition critical implant lines.

Clinically, tariff-driven cost pressures have influenced product selection dynamics; clinicians balance the benefits of premium materials such as titanium against more cost-efficient alternatives like stainless steel or emerging bioabsorbables, taking into account case complexity and long-term outcomes. In sum, the tariff environment accelerated strategic realignment across the value chain, elevating supply chain resilience, material flexibility, and regional manufacturing as enduring priorities.

In-depth segmentation analysis revealing how animal type, implant design, material science, end-user procurement, and clinical application jointly shape product strategy

Segment-level dynamics illuminate where clinical need, material science, and end-user behavior intersect to create differentiated opportunities. When analyzed by animal type, demand patterns diverge between small animals such as cats and dogs, large animals including bovine, equine, and porcine, and exotic categories exemplified by birds and reptiles; each segment imposes unique biomechanical and anatomical constraints that influence implant geometry, fixation strategy, and postoperative protocols. Similarly, implant type matters: plates and screws, with variants such as dynamic compression plates and locking plates, serve a broad range of fracture patterns, while intramedullary nails-both cannulated and solid-provide load-sharing solutions that are often preferred for long bone stabilization. External fixation options span ring and unilateral constructs that cater to complex or staged reconstructions, and interlocking nails provide rotational stability for select indications.

Material choice further differentiates product positioning with bioabsorbable polymers offering temporary support and reduced need for implant removal, ceramic coatings enhancing bone integration at the tissue-implant interface, and metals like stainless steel and titanium providing long-term structural reliability. End-user segmentation reveals distinct procurement behaviors across ambulatory surgical centers, research and academic institutes, veterinary clinics, and full-service veterinary hospitals; ambulatory centers frequently emphasize cost-efficiency and inventory turnover, academic centers prioritize innovation and evidence generation, clinics focus on workflow simplicity, and hospitals balance complexity with a need for comprehensive surgical portfolios. Finally, application-driven segmentation-fracture fixation, joint reconstruction, ligament repair, and osteotomy-maps clinical outcomes to design requirements and informs prioritization for R&D investment. Integrating these layers enables targeted product strategies that align design features with the nuanced needs of each clinical and operational context.

Comparative regional insights highlighting regulatory complexity, clinical adoption patterns, and distribution nuances across Americas, EMEA, and Asia-Pacific markets

Regional dynamics influence regulatory environments, clinician training ecosystems, and distribution networks, producing distinct strategic considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong private practice penetration, a mature companion animal care market, and advanced surgical training support rapid uptake of novel implant technologies, while distributors and group-practice consolidators exert influence over purchasing patterns and adoption curves. Regulatory pathways tend to balance safety with clinical access, creating predictable channels for innovators that demonstrate robust clinical evidence.

In Europe, Middle East & Africa, heterogeneity in reimbursement structures and diverse regulatory regimes demand adaptive go-to-market approaches. Western European centers often lead in early clinical adoption and research collaboration, whereas markets in the Middle East and Africa vary widely in infrastructure and procurement sophistication, which impacts the feasibility of premium implant introductions. Across the Asia-Pacific region, a mix of high-volume public hospitals, growing private specialty clinics, and rapidly expanding veterinary services creates both scale opportunities and operational complexity. Local manufacturing capacity, especially in key Asia-Pacific hubs, can lower costs and improve responsiveness, but it also introduces competitive pressure from domestic producers that emphasize cost-value trade-offs.

Taken together, regional insights suggest that successful market entry and expansion require tailored regulatory strategies, localized clinician engagement programs, and flexible distribution models that reflect distinct payer, provider, and logistical realities.

Strategic company capabilities that drive commercial success through integrated service models, focused portfolios, and resilient manufacturing and clinical engagement

Company-level dynamics center on capabilities that extend beyond product attributes to encompass manufacturing flexibility, clinical partnerships, and service ecosystems that support adoption. Leading organizations are investing in modular instrumentation, surgeon training academies, and digital planning platforms that lower execution risk and create switching costs for procurement decision-makers. Some manufacturers emphasize vertically integrated supply chains to secure critical raw materials and to accelerate product iterations, while others pursue strategic partnerships and contract manufacturing to scale quickly without large capital expenditure.

Portfolio strategies differ: some companies prioritize breadth by offering comprehensive implant systems across multiple animal types and applications, enabling bundled purchasing relationships with hospital networks; others follow a focused playbook, concentrating on niche solutions such as bioabsorbable implants or species-specific designs to capture premium clinical share. Across the board, successful firms demonstrate disciplined post-market surveillance, publish clinical outcomes in peer-reviewed venues, and maintain active engagement with key opinion leaders to validate device performance in real-world settings. Finally, commercial excellence is increasingly defined by integrated service offerings-instrument reuse programs, sterilization logistics, and remote surgical planning support-that reduce operational friction for end users and reinforce long-term partnerships.

Actionable prioritized recommendations for industry leaders to optimize product roadmaps, fortify supply chains, and elevate clinical adoption through data and services

Industry leaders should pursue a set of pragmatic, prioritized actions to strengthen competitive position and respond to evolving market pressures. First, align product development roadmaps with clinician pain points by investing in modular systems and surgeon-centric instrumentation that reduce procedure time and variability, thereby increasing clinical uptake. Second, diversify sourcing and manufacturing footprints to reduce exposure to tariff volatility and to shorten lead times; nearshoring select production lines and qualifying alternate contract manufacturers can materially improve resilience.

Third, invest in evidence generation by supporting clinical trials and registries that demonstrate comparative outcomes across materials and implant types; robust data underpins premium pricing and facilitates payer and institutional adoption. Fourth, expand bundled service offerings that combine devices with training, digital planning, and post-sale support to create differentiated value propositions and improve customer retention. Fifth, tailor market-entry strategies to regional nuances by calibrating regulatory submissions, pricing approaches, and distribution models to local payer and provider structures. Finally, pursue selective partnerships with academic centers and specialty referral hospitals to co-develop novel solutions while leveraging those relationships to accelerate clinician education and product validation. Executed together, these actions balance short-term commercial pressures with long-term differentiation and growth potential.

Transparent multi-method research approach combining clinician interviews, literature triangulation, and supply chain analysis to validate segmentation and scenario insights

This research employs a structured, multi-method approach that integrates primary qualitative inputs with rigorous secondary analysis to ensure findings are robust and relevant to decision-makers. Primary research includes in-depth interviews with practicing veterinary surgeons, procurement professionals, and biomedical engineers, supplemented by structured clinician surveys that capture procedural preferences and material trade-offs. These inputs are triangulated against secondary sources such as peer-reviewed clinical literature, device registries, regulatory filings, and publicly available manufacturing and distribution data to validate trends and identify emergent patterns.

Methodologically, segmentation frameworks were developed to reflect real-world clinical and commercial decision levers, mapping animal type, implant design, material attributes, end-user behavior, and application to observable demand signals. Supply chain analysis focused on raw material flows, contract manufacturing relationships, and distribution channel structures to assess operational risk and time-to-market constraints. All analyses underwent internal validation through cross-functional expert review panels to test assumptions and ensure interpretive accuracy. Where appropriate, scenario analysis was used to explore the implications of tariff shocks, raw material disruptions, and accelerated adoption of new technologies, thus offering practical insight into resilience strategies and opportunity windows.

Concluding synthesis highlighting how innovation, evidence generation, and operational resilience will determine leadership in veterinary orthopedic implants

In conclusion, the veterinary orthopedic implant landscape is at an inflection point where clinical innovation, materials science, and operational exigencies intersect to create differentiated strategic pathways. Stakeholders who prioritize clinician-aligned design, invest in evidence generation, and build flexible manufacturing and distribution footprints will be best positioned to capture sustained value. Tariff-induced pressures have underscored the importance of supply chain diversification and regional manufacturing options, while advances in bioabsorbables, surface technologies, and additive manufacturing have expanded the repertoire of viable clinical interventions.

As the market evolves, success will be defined not solely by device performance but by the ability to deliver integrated solutions that reduce clinical friction, demonstrate clear outcome benefits, and adapt to regional market realities. Organizations that combine disciplined commercial execution with targeted investments in training, clinical partnerships, and post-sale services can accelerate adoption, improve patient outcomes, and secure long-term relationships with key end users. Moving forward, an evidence-driven, resilient, and service-oriented approach will separate market leaders from laggards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of custom 3D printed orthopedic implants for small animal patients
  • 5.2. Increasing integration of bioresorbable materials in veterinary bone fixation devices
  • 5.3. Surge in demand for minimally invasive techniques using arthroscopic-assisted implants
  • 5.4. Growing use of sensor-enabled smart implants for postoperative monitoring in animals
  • 5.5. Advancements in stem cell seeded scaffolds for enhanced orthopedic repair in pets
  • 5.6. Expansion of telemedicine platforms to support post-surgical orthopedic implant care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Orthopedic Implants Market, by Animal Type

  • 8.1. Exotic Animals
    • 8.1.1. Birds
    • 8.1.2. Reptiles
  • 8.2. Large Animals
    • 8.2.1. Bovine
    • 8.2.2. Equine
    • 8.2.3. Porcine
  • 8.3. Small Animals
    • 8.3.1. Cats
    • 8.3.2. Dogs

9. Veterinary Orthopedic Implants Market, by Implant Type

  • 9.1. External Fixators
    • 9.1.1. Ring Fixators
    • 9.1.2. Unilateral Fixators
  • 9.2. Interlocking Nails
  • 9.3. Intramedullary Nails
    • 9.3.1. Cannulated Nails
    • 9.3.2. Solid Nails
  • 9.4. Plates And Screws
    • 9.4.1. DCP Plates
    • 9.4.2. Locking Plates

10. Veterinary Orthopedic Implants Market, by Material Type

  • 10.1. Bioabsorbable Polymers
  • 10.2. Ceramic Coatings
  • 10.3. Stainless Steel
  • 10.4. Titanium

11. Veterinary Orthopedic Implants Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Research And Academic Institutes
  • 11.3. Veterinary Clinics
  • 11.4. Veterinary Hospitals

12. Veterinary Orthopedic Implants Market, by Application

  • 12.1. Fracture Fixation
  • 12.2. Joint Reconstruction
  • 12.3. Ligament Repair
  • 12.4. Osteotomy

13. Veterinary Orthopedic Implants Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Orthopedic Implants Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Orthopedic Implants Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. DePuy Synthes, Inc.
    • 16.3.2. Zimmer Biomet Holdings, Inc.
    • 16.3.3. Stryker Corporation
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Arthrex, Inc.
    • 16.3.6. BioMedtrix, Inc.
    • 16.3.7. IMEX Veterinary Inc.
    • 16.3.8. Kyon AG
    • 16.3.9. Orthomed, Inc.
    • 16.3.10. B. Braun Melsungen AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VETERINARY ORTHOPEDIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VETERINARY ORTHOPEDIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY ORTHOPEDIC IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

TA